SCHEMBL8622953

SCHEMBL8622953

Cc1ccc(CC(c2ccc(Cl)cc2)C(C)N)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 2/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A4 P31645 2/20 0.48
ADRB2 P07550 1/20 0.46
CNR2 P34972 3/20 0.43
RAB9A P51151 3/20 0.42
NPC1 O15118 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
CNR1 P21554 3/20 0.41
FDFT1 P37268 1/20 0.41
POLB P06746 1/20 0.40
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8626123 1.00 SLC6A3 (0.55) SLC6A3SLC6A2SLC6A4ADRB2CNR2
SCHEMBL4691720 0.93 SLC6A3 (0.62) SLC6A3SLC6A2SLC6A4ADRB2CNR2
Hydrochloric Acid SCHEMBL3371509 0.91 SLC6A2 (0.60) SLC6A3SLC6A2SLC6A4ADRB2CNR2
SCHEMBL8621289 0.88 SLC6A2 (0.56) SLC6A3SLC6A2SLC6A4ADRB2CNR2
SCHEMBL8619441 0.88 SLC6A2 (0.56) SLC6A3SLC6A2SLC6A4ADRB2CNR2
SCHEMBL8623135 0.85 SLC6A2 (0.53) SLC6A3SLC6A2SLC6A4ADRB2CNR2
SCHEMBL8619498 0.85 SLC6A2 (0.53) SLC6A3SLC6A2SLC6A4ADRB2CNR2
SCHEMBL13068253 0.85 SLC6A2 (0.53) SLC6A3SLC6A2SLC6A4ADRB2CNR2
SCHEMBL8624790 0.85 TAAR1 (0.53) SLC6A3SLC6A2SLC6A4ADRB2CNR2
SCHEMBL3374924 0.85 SLC6A2 (0.56) SLC6A3SLC6A2SLC6A4CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5777150-A Substituted amic acid derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-07-07 US disclosed
EP-0611749-B1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMA CO LTD (JP) 1997-10-22 EP disclosed
US-5616803-A EXHIBIT SQUALENE SYNTHASE-INHIBITORY ACTIVITIES; USEFUL IN TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA, HYPERLIPEMIA AND ARTERIOSCLEROSIS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-04-01 US disclosed
US-5606101-A INTERMEDIATES FOR SQUALENE SYNTHASE INHIBITORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-02-25 US disclosed
US-5488149-A SQUALENE SYNTHASE INHIBITORS AS ANTICHOLESTEROL OR ANTILIPEMIC AGENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-01-30 US disclosed
EP-0611749-A1 Substituted amic acid derivatives useful for treatment of arteriosclerosis BANYU PHARMACEUTICAL CO., LTD. (JP) 1994-08-24 EP disclosed